Frangufoline

CAS No. 19526-09-1

Frangufoline( ——— )

Catalog No. M38971 CAS No. 19526-09-1

Frangufoline is a 4(14)-type cyclopeptide alkaloid, that can be isolated from the root bark extract of Ziziphus cambodiana Pierre.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Frangufoline
  • Note
    Research use only, not for human use.
  • Brief Description
    Frangufoline is a 4(14)-type cyclopeptide alkaloid, that can be isolated from the root bark extract of Ziziphus cambodiana Pierre.
  • Description
    Frangufoline is a sedative 14-membered frangulanine-type cyclopeptide alkaloid.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    19526-09-1
  • Formula Weight
    534.701
  • Molecular Formula
    C31H42N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    H2O : 5 mg/mL (9.35 mM; ultraphonic)
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lomchoey N, et al. New bioactive cyclopeptide alkaloids with rare terminal unit from the root bark of Ziziphus cambodiana. RSC Adv. 2018 May 17;8(33):18204-18215. ?
molnova catalog
related products
  • Zoliprofen

    Zoliprofen is a potent and orally available non-steroidal anti-inflammatory agent with anti-inflammatory, antipyretic and analgesic activity, and inhibits carobolin, mycobacterium, and knife-ball protein A-induced rat paw oedema, as well as anti-rat serum-induced fracture or dorsal skin oedema.

  • AMPPD

    AMPPD is a 1,2-dioxo-cyclohexane derivative and a substrate for hypersensitive alkaline phosphatase.

  • Dyngo-4a

    Dyngo-4a , a effective dynamin inhibitor, inhibits withDynI (brain), DynI (rec), and DynII (rec) of IC50 of 0.38 μM, 1.1 μM, and 2.3 μM, respectively.